Apyx Medical (APYX) Net Income towards Common Stockholders Growth (1y) (2012 - 2026)
Apyx Medical (APYX) Net Income towards Common Stockholders Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Apyx Medical | 179.34 Mn | 148.46 Mn | 7.93 Mn | 49.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.20% |
| Dec 31, 2025 | 71.93% |
| Sep 30, 2025 | 57.81% |
| Jun 30, 2025 | 42.37% |
| Mar 31, 2025 | 45.22% |
| Dec 31, 2024 | 51.83% |
| Sep 30, 2024 | -1.60% |
| Jun 30, 2024 | -543.38% |
| Mar 31, 2024 | -114.50% |
| Dec 31, 2023 | -58.40% |
| Sep 30, 2023 | 20.12% |
| Jun 30, 2023 | 81.30% |
| Mar 31, 2023 | 40.82% |
| Dec 31, 2022 | -201.74% |
| Sep 30, 2022 | -36.87% |
| Jun 30, 2022 | -34.53% |
| Mar 31, 2022 | -21.67% |
| Dec 31, 2021 | -31.29% |
| Sep 30, 2021 | -13.39% |
| Jun 30, 2021 | 13.62% |